跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oxasaph-100 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Oxasaph-100
Approved
STANDARD
Oxasaph-100
Bruck Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bddbf6745dcafe7c
Company
Bruck Pharma Private Limited
Type
Standard
Approval Details
Approval Id
bddbf6745dcafe7c
Drug Approval Philippines Name
Oxasaph-100
Product Name
Oxasaph-100
Registration Number
DRP-11224
Brand Name
Oxasaph-100
Generic Name
Oxaliplatin
Dosage Form
Lyophilized Powder for Injection (IV Infusion)
Dosage Strength
100 mg
Manufacturer
Bruck Pharma Private Limited
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 April 2023
Expiry Date
15 February 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bddbf6745dcafe7c
Type
Standard
Back to Philippines FDA Approvals